Last $2.95 USD
Change Today -0.01 / -0.34%
Volume 80.7K
FCSC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

fibrocell science inc (FCSC) Snapshot

Open
$2.93
Previous Close
$2.96
Day High
$3.07
Day Low
$2.93
52 Week High
03/14/14 - $6.30
52 Week Low
09/15/14 - $2.60
Market Cap
120.5M
Average Volume 10 Days
59.3K
EPS TTM
$-1.06
Shares Outstanding
40.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FIBROCELL SCIENCE INC (FCSC)

fibrocell science inc (FCSC) Related Bloomberg News

View More Bloomberg News

fibrocell science inc (FCSC) Related Businessweek News

No Related Businessweek News Found

fibrocell science inc (FCSC) Details

Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing various treatments for skin diseases and conditions with unmet medical needs. The company, through its proprietary autologous fibroblast technology, Fibrocell, develops biologic solutions and medical applications of azficel-T for restrictive burn scarring and vocal cord scarring conditions; and biologic products for patients with rare genetic skin and tissue disorders. It has collaboration agreements with Intrexon Corporation for using genetically-modified fibroblasts for treating rare and serious skin, and connective tissue diseases; and University of California, Los Angeles to focus on skin-derived stem cells and other ways to convert skin cells to other cell types. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was founded in 1995 and is headquartered in Exton, Pennsylvania.

58 Employees
Last Reported Date: 06/2/14
Founded in 1995

fibrocell science inc (FCSC) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $454.8K
Vice President of Human Resources and Busines...
Total Annual Compensation: $199.4K
Vice President of Scientific Affairs
Total Annual Compensation: $188.0K
Vice President of Quality
Total Annual Compensation: $148.8K
Executive Vice President of Marketing
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

fibrocell science inc (FCSC) Key Developments

Fibrocell Science, Inc. Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-07-2014 02:30 PM

Fibrocell Science, Inc. Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-07-2014 02:30 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States.

Fibrocell Science, Inc. Announces Management Changes on October 2, 2014

Fibrocell Science, Inc. announced that, as of October 2, 2014, Gregory Weaver is no longer employed by the company. Mr. Weaver served as Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary of the company. The company will begin a search for a successor Chief Financial Officer. On October 2, 2014, the Board of Directors of the company appointed Kimberly M. Smith, the company's Controller, to serve as Interim Chief Financial Officer, Treasurer and Corporate Secretary, effective immediately. Ms. Smith, 37, will continue to serve as the Controller of the company, a position she has held since January 2014. Prior to joining the company, Ms. Smith was a financial consultant with AC Lordi Corporation from 2010 to 2013 working exclusively for AC Lordi Corporation's client, ViroPharma Incorporated. From 2004 to 2010, Ms. Smith was a financial consultant with The Siegfried Group, LLP, representing a variety of clients. Prior to joining The Siegfried Group, LLP, Ms. Smith was a financial analyst for Motorola, Inc. from 2002 to 2004. Ms. Smith began her career as a staff accountant at Ernst & Young LLP from 1998 to 2000 and as a senior accountant from 2000 to 2002. Ms. Smith is a Certified Public Accountant and also holds the Chartered Global Management Accountant designation.

Fibrocell Science, Inc. Presents at The 21st Annual NewsMakers in the Biotech Industry 2014, Sep-26-2014 09:30 AM

Fibrocell Science, Inc. Presents at The 21st Annual NewsMakers in the Biotech Industry 2014, Sep-26-2014 09:30 AM. Venue: Millennium Broadway Hotel & Conference Center, 145 West 44th Street, New York, New York, United States. Speakers: David M. Pernock, Chairman, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCSC:US $2.95 USD -0.01

FCSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FCSC.
View Industry Companies
 

Industry Analysis

FCSC

Industry Average

Valuation FCSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIBROCELL SCIENCE INC, please visit www.fibrocellscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.